Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-type-targeted mitochondrial transplantation rescues cell degeneration.

Nature·2026
Same author

Cell-type-focused compound screen in human organoids reveals CK1 inhibition protects cone photoreceptors from death.

Neuron·2026
Same author

Retinal ganglion cell survival and functional maturation in transiently vascularized human retinal organoids.

Cell stem cell·2026
Same author

High-efficiency base editing in the retina in primates and human tissues.

Nature medicine·2025
Same author

PEGDA-based HistoBrick for increasing throughput of cryosectioning and immunohistochemistry in organoid and small tissue studies.

Scientific reports·2025
Same author

Corrigendum: Toward Retinal Organoids in High-Throughput.

Cold Spring Harbor perspectives in medicine·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 29, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

3.5K

Toward Retinal Organoids in High-Throughput.

Stefan Erich Spirig1,2, Magdalena Renner3,2

  • 1Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.

Cold Spring Harbor Perspectives in Medicine
|May 22, 2023
PubMed
Summary
This summary is machine-generated.

Generating scalable human retinal organoids (HROs) is crucial for therapy development. This review explores methods to increase HRO production and analysis efficiency, reducing manual labor for widespread application.

More Related Videos

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells
10:05

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Published on: April 12, 2021

6.0K
Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells
06:38

Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells

Published on: April 21, 2021

3.0K

Related Experiment Videos

Last Updated: Jul 29, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

3.5K
Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells
10:05

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Published on: April 12, 2021

6.0K
Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells
06:38

Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells

Published on: April 21, 2021

3.0K

Area of Science:

  • Biomedical Engineering
  • Stem Cell Biology
  • Ophthalmology

Background:

  • Human retinal organoids (HROs) model retinal development and disease.
  • Current HRO generation protocols are labor-intensive and require long maturation times.
  • Scaling up HRO production is essential for therapeutic and screening applications.

Purpose of the Study:

  • To review strategies for increasing the yield and quality of HROs.
  • To discuss methods for reducing manual handling in HRO production.
  • To explore high-throughput analysis techniques for HROs.

Main Methods:

  • Review of existing literature on HRO generation and analysis.
  • Discussion of automation and miniaturization techniques.
  • Examination of current high-throughput screening and analysis platforms.

Main Results:

  • Several strategies exist to enhance HRO production scalability.
  • Automation and reduced manual steps can improve efficiency.
  • High-throughput analysis methods are emerging but face challenges.

Conclusions:

  • Optimizing HRO production and analysis is critical for advancing retinal therapies.
  • Further innovation is needed to overcome current limitations in scale and efficiency.
  • Standardized, scalable protocols will accelerate drug discovery and regenerative medicine.